EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer

Zhiyue Liu, Mei Liu, Xiaorong Zhong, Yupei Qin, Ting Liang, Ting Luo, Xi Yan, Zhuoqin Tang, Xi Wang, Shichu Liang iD, Qian Li, Xiaomiao Ruan und 2 weitere

Cancer Medicine · 2023

DOI: 10.1002/cam4.6039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Zhiyue Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, West China Hospital of Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Ventricular Dysfunction, Left. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer therapy‐related cardiovascular toxicity (CTR‐CVT) is a major contributor to poor prognosis in breast cancer (BC) patients undergoing chemotherapy. Left ventricular global longitudinal strain (LV GLS) has predictive value for CTR‐CVT, while few researchers take into account late‐onset CTR‐CVT. This study sought to provide a guide for the prediction of late‐onset CTR‐CVT in primary BC over the 2 years follow‐up via strain and contrast‐enhanced echocardiography.

Methods

Anthracycline and anthracycline + targeted medication groups were created from 111 patients with stage I–III primary BC who were prospectively included. The left ventricular diastolic function, LV global long‐axis strain (GLS); left ventricular ejection fraction by contrast‐enhanced echocardiography (c‐LVEF), and electrocardiograms were collected at baseline, 3, 6, 12, and 24 months after the start of cancer treatment. The high‐sensitivity troponin‐T and NT‐pro BNP at baseline and 3 months after chemotherapy were measured.

Results

(1) LV GLS decreased in BC patients over time. (2) After 12 months' follow‐up, the LV GLS in the anthracycline+ targeted group was lower than in the anthracycline group. After 24 months' follow‐up, the GLS and c‐LVEF in the anthracycline + targeted group declined while the E/e’ increased. (3) Decreased LVEF (56%) and arrhythmia (38%) are the common causes of CTR‐CVT. Lower LVEF was a major factor in late‐onset CTR‐CVT. (4) Combination of LV GLS and c‐LVEF at 3 months were used as predictors for CTR‐CVT and exhibited a higher AUC than either one alone (AUC = 0.929, 95% CI: 0.863–0.970). LV GLS at 3 months can predict the late‐onset CTR‐CVT (AUC = 0.745, p < 0.001), and the cut‐off is 20.32%.

Conclusions

As time went on, the systolic and diastolic dysfunction of BC patients get worsened. The combination of LV GLS and c‐LVEF is better in the prediction of CTR‐CVT. Only the LV GLS at 3 months can predict the late‐onset CTR‐CVT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsVentricular Dysfunction, LeftHumansFemaleCardiotoxicityVentricular Function, LeftStroke VolumeGlobal Longitudinal StrainAnthracyclines

Stichwörter der Autor:innen

breast cancercardio-oncologyechocardiographyheart failurelate-onset cardiotoxicity

Substanzen

Anthracyclines

Autor:innen und Institutionen

  • Department of Cardiology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Department of Oncology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Department of Ultrasound, West China Hospital of Sichuan University, Chengdu, Sichuan, China.

ORCID-Profile: Shichu Liang, He Huang

Förderung

  • Department of Science and Technology of Sichuan Province

Zitieren

APA

Liu, Z., Liu, M., Zhong, X., Qin, Y., Liang, T., Luo, T., Yan, X., Tang, Z., Wang, X., Liang, S., Li, Q., Ruan, X., He, W., & Huang, H. (2023). Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer. Cancer Medicine. https://doi.org/10.1002/cam4.6039

Vancouver

Liu Z, Liu M, Zhong X, Qin Y, Liang T, Luo T, et al. Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer. Cancer Medicine. 2023. doi:10.1002/cam4.6039

BibTeX
@article{Liu2023,
  author = {Liu, Zhiyue and Liu, Mei and Zhong, Xiaorong and Qin, Yupei and Liang, Ting and Luo, Ting and Yan, Xi and Tang, Zhuoqin and Wang, Xi and Liang, Shichu and Li, Qian and Ruan, Xiaomiao and He, Wenfeng and Huang, He},
  title = {Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.6039}
}
Kostenlos starten →